Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes

Ahlén, G.; Derk, E.; Weiland, M.; Jiao, J.; Rahbin, N.; Aleman, S.; Peterson, D. L.; Pokrovskaja, K.; Grandér, D.; Frelin, L.; Sällberg, M.
April 2009
Gut;Apr2009, Vol. 58 Issue 4, p560
Academic Journal
Aims: To test if HCV NS3/4A affects innate and adaptive immune responses in vivo. Methods: NS3 levels were semi-quantified in human liver biopsies, transfected cells, and in transgenic (Tg) mouse livers by western blot. The effect of NS3/4A on dsRNA-mediated signalling and on the integrity of IPS-1 was analysed using in vitro translation, transfected cells and Tg mice. Cytotoxic T cell (CTL)-mediated clearance of transient firefly luciferase (FLuc)- and/or NS3/4A-Tg hepatocytes was determined using in vivo imaging and western blot. Results: NS3 protein levels were in a comparable range (0.1-49 μg/g tissue) in infected human livers and Tg mouse livers. Importantly, these levels of NS3/4A reduced murine innate responses to synthetic dsRNA in vivo, supporting the possibility that this occurs also in infected humans. The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1. Despite this, FLuc- and/or NS3/4A-expressing murine hepatocytes were effectively eliminated by hepatic CTLs, utilising the classical molecules for virus-infected cell lysis, including CD8, IFNγ, perforin and FasL. Conclusions: Although HCV NS3/4A inhibits the innate immunity, this does not prevent CTL-mediated clearance of NS3/4A-expressing hepatocytes in vivo. Thus, other HCV proteins are most likely responsible for interfering with the adaptive immunity.


Related Articles

  • Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Dorner, Marcus; Horwitz, Joshua A.; Donovan, Bridget M.; Labitt, Rachael N.; Budell, William C.; Friling, Tamar; Vogt, Alexander; Catanese, Maria Teresa; Satoh, Takashi; Kawai, Taro; Akira, Shizuo; Law, Mansun; Rice, Charles M.; Ploss, Alexander // Nature;9/12/2013, Vol. 501 Issue 7466, p237 

    More than 130 million people worldwide chronically infected with hepatitis C virus (HCV) are at risk of developing severe liver disease. Antiviral treatments are only partially effective against HCV infection, and a vaccine is not available. Development of more efficient therapies has been...

  • Diurnal dynamics of cytokine spectrum produced by immunocompetent cells of intact mice. I. Kovshik; A. Shurlygina; S. Sennikov; A. Silkov; V. Trufakin // Bulletin of Experimental Biology & Medicine;Oct2007, Vol. 144 Issue 4, p566 

    Abstract  The production of cytokines by immunocompetent cells of intact mice was studied in various phases of the diurnal cycle. The ratio of produced cytokines was shown to differ in various phases of the diurnal cycle. The correlation between spontaneous production of various cytokines...

  • Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo. Wenbo Zhu; Chunchen Wu; Wanyu Deng; Rongjun Pei; Yun Wang; Liang Cao; Bo Qin; Mengji Lu; Xinwen Chen; Sung Key Jang // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    The hepatitis C virus (HCV) core protein is a multifunctional protein that can interfere with the induction of an immune response. It has been reported that the HCV core protein inhibits HBV replication in vitro. In this study, we test the effect of the HCV core gene on the priming of the immune...

  • Increase in Muscle Mitochondrial Biogenesis Does Not Prevent Muscle Loss but Increased Tumor Size in a Mouse Model of Acute Cancer-Induced Cachexia. Wang, Xiao; Pickrell, Alicia M.; Zimmers, Teresa A.; Moraes, Carlos T. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Cancer-associated cachexia is a complex metabolic condition characterized by the progressive loss of body fat and deterioration of muscle mass. Although the cellular and molecular mechanisms of cachexia are incompletely understood, previous studies have suggested mitochondrial dysfunction in...

  • The murine cellular immune response to adenovirus type 5. Müllbacher, A.; Bellett, A. J. D.; Hla, R. T. // Immunology & Cell Biology;Feb1989, Vol. 67 Issue 1, p31 

    We have characterized the cellular immune response to human adenovirus 5 (Ad-5) in mice, as a basis for future study of responses to foreign antigens in recombinant adenoviruses. Primary in vivo lytic effector cells contained both virus immune cytolytic T (Tc) cells and natural killer cells. The...

  • T cell responses: A new starting point. Leavy, Olive // Nature Reviews Immunology;Jul2009, Vol. 9 Issue 7, p462 

    The article discusses a study which indicates that the induction of T cell responses can occur in the liver in the absence of lymphoid tissues. In initiating a T cell-mediated immune response to subcutaneous antigen without lymphoid tissues, the authors of the study showed that antigen is...

  • Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis. Sionov, Edward; Mayer-Barber, Katrin D.; Chang, Yun C.; Kauffman, Keith D.; Eckhaus, Michael A.; Salazar, Andres M.; Barber, Daniel L.; Kwon-Chung, Kyung J. // PLoS Pathogens;8/7/2015, Vol. 11 Issue 8, p1 

    Cryptococcus neoformans is the most common cause of fungal meningoencephalitis in AIDS patients. Depletion of CD4 cells, such as occurs during advanced AIDS, is known to be a critical risk factor for developing cryptococcosis. However, the role of HIV-induced innate inflammation in...

  • Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. K. Inagaki-Ohara; A. Sasaki; G. Matsuzaki; I. Ikeda; M. Hotokezaka; K. Chijiiwa; M. Kubo; H. Yoshida; Y. Nawa; A. Yoshimura // Gut;Feb2006, Vol. 55 Issue 2, p212 

    Background and aims: Imbalance between pro- and anti-inflammatory cytokines produced by intestinal T cells induces inflammatory bowel diseases (IBD). However, the importance of regulation of cytokine signalling in IBD has not been fully clarified. We have demonstrated that suppressor of cytokine...

  • 626. Inactivated Sendai Virus Particle (HVJ-E) Solely Induces Specific Anti-Tumor Immune Response and Eradicates Murine Carcinoma. Kurooka, Masayuki; Kaneda, Yasufumi // Molecular Therapy;Jun2006, Vol. 13, pS241 

    Inactivated Sendai virus particle (Hemagglutinating virus of Japan envelope, HVJ-E) has been developed as a safe and efficient non- viral vector for gene delivery system. Now, we discovered that empty HVJ-E solely could induce specific anti-tumor immune response and eradicated growing tumors in...


Read the Article


Sign out of this library

Other Topics